Skip to main content
Andrew Craig PhD
 Andrew Craig
Principal Investigator, CBG Division
Contact Info

Faculty Bio

My lab studies tyrosine kinase signaling pathways that regulate cell motility, tissue invasion and inflammation. We currently have projects focusing on mast cells, that produce a wide array of mediators that can remodel tissues during immune responses and regulate tumour progression. We also study contributions of F-BAR proteins in metastatic cancers using cell and mouse models.

“Currently seeking qualified PhD students with interest in cancer therapeutic development” (02 May 2017).

Research Interests:

Defining targets and new therapies in metastatic cancers

The Craig lab has several projects related to molecular mechanisms of cancer progression, immune suppression, and metastasis:

  1. Tumour suppressor miRNA targets and pathways
  2. Developing new tools to target actin-driven cancer metastasis
  3. Targeting immune suppression pathways in metastatic cancers
  4. Functional genomic screening to identify vulnerabilities in inflammatory breast cancer
  5. Defining circulating miRNA biomarkers in lung cancer patients treated with immunotherapy

Interested in joining the team, or to get more information, contact

Our research in the news:

This research has been made possible by current or former support from Queen’s University Research Opportunities Fund, Canadian Institutes for Health Research, Cancer Research Society, and Canadian Cancer Society Research Institute.


Craig Lab